Fingerprint
Dive into the research topics where Janet Tu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A Multicenter Open-Label Randomized Phase II Study of Osimertinib with and Without Ramucirumab in Tyrosine Kinase Inhibitor-Naïve EGFR -Mutant Metastatic Non-Small Cell Lung Cancer (RAMOSE trial)
Le, X., Patel, J. D., Shum, E., Baik, C., Sanborn, R. E., Shu, C. A., Kim, C., Fidler, M. J., Hall, R., Elamin, Y. Y., Tu, J., Blumenschein, G., Zhang, J., Gibbons, D., Gay, C., Mohindra, N. A., Chae, Y., Boumber, Y., Sabari, J. & Santana-Davila, R. & 10 others, , Feb 1 2025, In: Journal of Clinical Oncology. 43, 4, p. 403-411 9 p.Research output: Contribution to journal › Article › peer-review
Open Access43 Link opens in a new tab Scopus citations -
Longitudinal Tracking of ALK-Rearranged NSCLC From Plasma Using Circulating Tumor RNA and Circulating Tumor DNA
Heeke, S., Gandhi, S., Tran, H. T., Lam, V. K., Byers, L. A., Gibbons, D. L., Gay, C. M., Altan, M., Antonoff, M. B., Le, X., Tu, J., Saad, M. B., Pek, M., Poh, J., Ngeow, K. C., Tsao, A., Cascone, T., Negrao, M. V., Wu, J. & Blumenschein, G. R. & 2 others, , Apr 2025, In: JTO Clinical and Research Reports. 6, 4, 100795.Research output: Contribution to journal › Article › peer-review
Open Access6 Link opens in a new tab Scopus citations -
Multi-Institution Analysis of Tarlatamab for the Treatment of EGFR-Mutant Transformed Small Cell Lung Cancer
Cooper, A. J., Herzberg, B., Parma, M., Wang, K., Alder, L., Weber, U. M., Patil, T., Joshi, U., Puri, S., Saqi, A., Clark, P., Gay, C. M., Cascone, T., Singhi, E. K., Blumenschein, G., Skoulidis, F., Tu, J., Stinchcombe, T. E., Rudin, C. M. & Shu, C. A. & 3 others, , Oct 2025, In: JCO Precision Oncology. 9Research output: Contribution to journal › Article › peer-review
1 Link opens in a new tab Scopus citations -
Author Correction: Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy (Nature Communications, (2022), 13, 1, (1970), 10.1038/s41467-022-29539-3)
Kim, S. T., Chu, Y., Misoi, M., Suarez-Almazor, M. E., Tayar, J. H., Lu, H., Buni, M., Kramer, J., Rodriguez, E., Hussain, Z., Neelapu, S. S., Wang, J., Shah, A. Y., Tannir, N. M., Campbell, M. T., Gibbons, D. L., Cascone, T., Lu, C., Blumenschein, G. R. & Altan, M. & 18 others, , Dec 2024, In: Nature communications. 15, 1, 5621.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Identifying MAGE-A4-positive tumors for TCR T cell therapies in HLA-A∗02-eligible patients
Wang, T., Navenot, J. M., Rafail, S., Kurtis, C., Carroll, M., Van Kerckhoven, M., Van Rossom, S., Schats, K., Avraam, K., Broad, R., Howe, K., Liddle, A., Clayton, A., Wang, R., Quinn, L., Sanderson, J. P., McAlpine, C., Carozza, C., Pimpinella, E. & Hsu, S. & 13 others, , Jun 13 2024, In: Molecular Therapy Methods and Clinical Development. 32, 2, 101265.Research output: Contribution to journal › Article › peer-review
Open Access16 Link opens in a new tab Scopus citations